Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB
- Authors
- Do, Y. R.; Kwak, J. -Y.; Kim, H.; Kim, J. -A.; Kim, H. J.; Park, J. S.; Chung, J. S.; Shin, H. -J.; Kim, S. -H.; Kim, D. -Y.; Bunworasate, U.; Choi, C. W.; Comia, N. S.; Zang, D. Y.; Oh, S. J.; Jootar, S.; Reksodiputro, A. H.; Lee, W. S.; Mun, Y. -C.; Kong, J. H.; Caguioa, P. B.; Park, J.; Jung, C. W.; Kim, D. -W.
- Issue Date
- Jun-2017
- Publisher
- FERRATA STORTI FOUNDATION
- Citation
- HAEMATOLOGICA, v.102, pp.441 - 441
- Journal Title
- HAEMATOLOGICA
- Volume
- 102
- Start Page
- 441
- End Page
- 441
- ISSN
- 0390-6078
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Park, Jinny
- College of Medicine (Department of Medicine)